Prostate Cancer - Results from #28440

Phase II evaluation of early oral estramustine, oral etoposide, and intravenous paclitaxel combined with hormonal therapy in patients with high-risk metastatic prostate adenocarcinoma: Southwest Oncology Group S0032 - Abstract March 17, 2011

Prostate cancer gene 3 urine assay for prostate cancer in Japanese men undergoing prostate biopsy - Abstract March 16, 2011

Industry-based retrospective cohort study of the risk of prostate cancer among rotating-shift workers - Abstract March 16, 2011

Correlation of prostate-specific antigen nadir and biochemical failure after high-intensity focused ultrasound of localized prostate cancer based on the Stuttgart failure criteria - analysis from the @-Registry - Abstract March 16, 2011

Inapparent tumor on endorectal multimodality magnetic resonance imaging of prostate: Should we perform a biopsy? - Abstract March 16, 2011

Focal therapy for localized prostate cancer: A phase I/II trial - Abstract March 16, 2011

Association of statin use with pathological tumor characteristics and prostate cancer recurrence after surgery - Abstract March 16, 2011

Urinary PCA3 score predicts prostate cancer multifocality - Abstract March 16, 2011

A model to predict prostate cancer after atypical findings in initial prostate needle biopsy - Abstract March 16, 2011

Physician assessment of pretreatment functional status: A process-outcomes link - Abstract March 16, 2011

Editor's Commentary - Spirituality and end-of-life care in disadvantaged men dying of prostate cancer March 16, 2011

Weight gain is associated with an increased risk of prostate cancer recurrence after prostatectomy in the PSA era - Abstract March 15, 2011

Safety profile of robot-assisted radical prostatectomy: A standardized report of complications in 3317 patients - Abstract March 15, 2011

Prostate cancer staging and grading at radical prostatectomy over time - Abstract March 15, 2011

Patients with localised prostate cancer (t1 - t2) show improved overall long-term survival compared to the normal population - Abstract March 15, 2011

Hormone depletion-insensitivity of prostate cancer cells is supported by the AR without binding to classical response elements - Abstract March 15, 2011

Cone beam CT pre- and post-daily treatment for assessing geometrical and dosimetric intrafraction variability during radiotherapy of prostate cancer - Abstract March 15, 2011

Sipuleucel-T: Harbinger of a new age of therapeutics for prostate cancer - Abstract March 15, 2011

Research shows rapid adoption of newer, more expensive prostate cancer treatments March 15, 2011

Predictors of physical activity and quality of life in New Zealand prostate cancer survivors undergoing androgen-deprivation therapy - Abstract March 14, 2011

Page 1423 of 1436